'Mirnas' presentation slideshows

Online Quiz

640 views • 43 slides

So... why are you here?

517 views • 42 slides

Role of micro-RNAs in Atrial Fibrillation

Role of micro-RNAs in Atrial Fibrillation. Amir Shaikh, MD; David D McManus, MD,ScM Assistant Professor, Department of Medicine University of Massachusetts Medical School, Worcester, MA, USA. Disclosures. David D McManus, MD, ScM has received research funding from:

456 views • 36 slides

??? ???????????? Tel. (Fax.): 86-25-86862756 Email: hbshen@njmu

?? miRNA ????????????. ??? ???????????? Tel. (Fax.): 86-25-86862756 Email: hbshen@njmu.edu.cn. MicroRNAs and Cancer. (1) In the nucleus, pri-miRNAs processed by Drosha as pre-miRNAs; (2) pre-miRNAs exported by Exportin-5 into cytoplasm; (3) Processed by Dicer as mature miRNAs ;

398 views • 25 slides

Chenghai Xue, Fei Li, Tao He, Guo-Ping Liu, Yanda Li, and Xeugong Zhang

Classification of real and pseudo microRNA precursors using local structure-sequence features and support vector machine. Chenghai Xue, Fei Li, Tao He, Guo-Ping Liu, Yanda Li, and Xeugong Zhang. CISC 841 Bioinformatics Nehar. Background: miRNAs.

392 views • 24 slides

MicroRNA identification based on sequence and structure alignment

196 views • 19 slides

2002.09.17

Drosha. 2002.09.17. 121th Lab meeting. ?? 2 ? ? ? ?. Lin-4, Let-7. What is RNAi ?. A form of posttranscriptional gene silencing , in which dsRNA induces degradation of the homologous mRNA, mimicking the effect of the reduction, or loss, of gene activity.

269 views • 18 slides

Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease

294 views • 18 slides

Post-Transcriptional Gene Silencing (PTGS)

Post-Transcriptional Gene Silencing (PTGS). Also called RNA interference or RNAi Process results in down-regulation of a gene at the RNA level (i.e., after transcription) There is also gene silencing at the transcriptional level (TGS)

638 views • 17 slides

MicroRNAs as novel Biomarkers for Breast Cancer treatment

MicroRNAs as novel Biomarkers for Breast Cancer treatment. Presentation by :Fariba Karami Department of New sciences, Islamic Azad University Tehran Medical Branch, Tehran, Iran Supervisor :Mahdi Paryan

143 views • 14 slides

2014 ? 4 ? ???????

2014 ? 4 ? ???????. ?? ? ???? ? ??????. Seminars In Cancer Biology. Cancer Discovery. A review of the current understanding and clinical utility of miRNAs in esophageal cancer

293 views • 13 slides

The Ability of Serum miRNAs to Act as Biomarkers for the Oral Squamous Cell Carcinoma.

The Ability of Serum miRNAs to Act as Biomarkers for the Oral Squamous Cell Carcinoma. Christopher Dickman Cathie Garnis Experimental Medicine Research Day. Background. Oral Squamous Cell Carcinoma (OSCC) is the most common form of head and neck cancer

294 views • 13 slides

Chun Zhao 11.01.12

The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 2010. Chun Zhao 11.01.12. About Placenta.

247 views • 11 slides

Fig. S1 Overview of small RNA sequencing data

Supplementary Figure Captions. Fig. S1 Overview of small RNA sequencing data

134 views • 6 slides

Nelson, PT_Suppl_Table2

143 views • 2 slides

GRB2

PDGFA: miR-30a /30a-5p/30b/30b-5p/ 30c de/384-5p; miR-135; miR-1/206; miR-23ab ; miR-196ab; miR-153; miR-221 /222; miR-194; miR-141/200a; miR-375

170 views • 2 slides

ABPI NaBDEN: Areas of interest for ITTP studentships

Cellular and molecular mechanisms that underpin organ toxicities, with special focus on CNS, the immune system, kidney, testicular, pulmonary, liver and cardiovascular toxicity

249 views • 1 slides

Growth factor

CASP9. mTOR. CDKN1A. BAD. CHUK. CDKN1B. FOXO1. MDM2. GSK3B. PDE3A/B. NOS3. Growth factor. GFR (e.g. ERBB2).

145 views • 1 slides